Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

13.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
13.4K
Human Virome01:26

Human Virome

47
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
47

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spiropyran-based glutamate nanovalve for neuronal stimulation.

Materials horizons·2025
Same author

Virus removal from semen with a pinched flow fractionation microfluidic chip.

Lab on a chip·2021
Same author

Sensing cell adhesion using polydiacetylene-containing peptide amphiphile fibres.

Journal of materials chemistry. B·2020
Same author

Polymorphic assembly of virus-capsid proteins around DNA and the cellular uptake of the resulting particles.

Journal of controlled release : official journal of the Controlled Release Society·2019
Same author

Immobilization of catalytic virus-like particles in a flow reactor.

Chemical communications (Cambridge, England)·2017
Same author

Photoresponsive, reversible immobilization of virus particles on supramolecular platforms.

Chemical communications (Cambridge, England)·2017

Related Experiment Video

Updated: May 2, 2026

Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

16.8K

Using viruses as nanomedicines.

H E van Kan-Davelaar1, J C M van Hest, J J L M Cornelissen

  • 1Department of Biomolecular Nanotechnology, MESA+ Institute for Nanotechnology, University of Twente, Enschede, The Netherlands.

British Journal of Pharmacology
|February 28, 2014
PubMed
Summary

Viruses are being engineered as nanomedicine delivery systems for targeted treatment of diseases like cancer and bacterial infections. These biodegradable viral nanoparticles offer a promising platform for novel therapeutic applications.

More Related Videos

Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"
09:23

Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"

Published on: March 31, 2021

6.3K
MicroRNA-based Regulation of Picornavirus Tropism
09:05

MicroRNA-based Regulation of Picornavirus Tropism

Published on: February 6, 2017

7.1K

Related Experiment Videos

Last Updated: May 2, 2026

Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

16.8K
Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"
09:23

Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"

Published on: March 31, 2021

6.3K
MicroRNA-based Regulation of Picornavirus Tropism
09:05

MicroRNA-based Regulation of Picornavirus Tropism

Published on: February 6, 2017

7.1K

Area of Science:

  • Nanomedicine
  • Molecular Engineering
  • Biotechnology

Background:

  • Nanomedicine focuses on designing nanocarriers for intracellular delivery and molecular diagnostics.
  • Viruses and bacteriophages are being repurposed as advanced molecular platforms for disease treatment.
  • Viral capsids, made of biodegradable proteins, can be engineered for various therapeutic and diagnostic functions.

Purpose of the Study:

  • To highlight recent advancements in engineering viruses for nanomedicine applications.
  • To explore the potential of engineered viruses in treating cancer, bacterial infections, and immune-related diseases.
  • To showcase the versatility of viral platforms in targeted delivery and molecular diagnostics.

Main Methods:

  • Genetic and chemical engineering of viral capsids.
  • Development of viral nanoparticles as drug delivery vehicles.
  • In vitro studies demonstrating viral vector capabilities.

Main Results:

  • Engineered viruses show promise as targeted delivery systems.
  • Viral platforms are being developed for cancer therapy and combating bacterial infections.
  • Potential applications in treating immune system-related diseases are emerging.

Conclusions:

  • Engineered viruses represent a significant advancement in nanomedicine.
  • Viral nanotechnology offers novel strategies for treating complex human diseases.
  • Further research into viral engineering holds great potential for future therapeutics.